HK1026146A1 - A universally applicable blood plasma - Google Patents

A universally applicable blood plasma

Info

Publication number
HK1026146A1
HK1026146A1 HK00105463A HK00105463A HK1026146A1 HK 1026146 A1 HK1026146 A1 HK 1026146A1 HK 00105463 A HK00105463 A HK 00105463A HK 00105463 A HK00105463 A HK 00105463A HK 1026146 A1 HK1026146 A1 HK 1026146A1
Authority
HK
Hong Kong
Prior art keywords
blood
blood plasma
universally applicable
plasma
applicable blood
Prior art date
Application number
HK00105463A
Other languages
English (en)
Inventor
Wolfgang Marguerre
Tor-Einar Svae
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1026146(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of HK1026146A1 publication Critical patent/HK1026146A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
HK00105463A 1997-08-05 2000-08-31 A universally applicable blood plasma HK1026146A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97113466A EP0896824A1 (en) 1997-08-05 1997-08-05 A universally applicable blood plasma
PCT/EP1998/004841 WO1999007390A1 (en) 1997-08-05 1998-08-04 A universally applicable blood plasma

Publications (1)

Publication Number Publication Date
HK1026146A1 true HK1026146A1 (en) 2000-12-08

Family

ID=8227172

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105463A HK1026146A1 (en) 1997-08-05 2000-08-31 A universally applicable blood plasma

Country Status (25)

Country Link
US (1) US20110008459A1 (id)
EP (2) EP0896824A1 (id)
JP (1) JP2001513507A (id)
CN (1) CN1272061A (id)
AT (1) ATE225665T1 (id)
AU (1) AU742427B2 (id)
BG (1) BG64350B1 (id)
BR (1) BR9811839A (id)
CA (1) CA2299421C (id)
CZ (1) CZ293726B6 (id)
DE (1) DE69808620T3 (id)
DK (1) DK0991416T4 (id)
EA (1) EA003182B1 (id)
ES (1) ES2185218T5 (id)
HK (1) HK1026146A1 (id)
HU (1) HU226548B1 (id)
ID (1) ID24308A (id)
IL (1) IL134308A (id)
NO (1) NO326216B1 (id)
NZ (1) NZ502661A (id)
PL (1) PL193983B1 (id)
PT (1) PT991416E (id)
RS (1) RS50016B (id)
TW (1) TW555563B (id)
WO (1) WO1999007390A1 (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
AU2004298790B2 (en) * 2003-12-19 2010-04-08 Octapharma Ag A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US9867782B2 (en) * 2009-04-09 2018-01-16 Entegrion, Inc. Spray-dried blood products and methods of making same
US8407912B2 (en) 2010-09-16 2013-04-02 Velico Medical, Inc. Spray dried human plasma
WO2011035062A2 (en) 2009-09-16 2011-03-24 Velico Medical, Inc. Spray dried human plasma
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
US20140083628A1 (en) 2012-09-27 2014-03-27 Velico Medical, Inc. Spray drier assembly for automated spray drying
CA2816090A1 (en) 2010-10-29 2012-05-03 Velico Medical, Inc. System and method for spray drying a liquid
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr) 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
FR3083121B1 (fr) 2018-06-27 2021-10-22 Maco Pharma Sa Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
JP2022525742A (ja) 2019-03-14 2022-05-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥用ローディングトレイ組立体及びシステム
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) * 1986-05-14 1995-03-15 株式会社ミドリ十字 血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) † 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
JP3575770B2 (ja) * 1992-03-31 2004-10-13 学校法人藤田学園 血漿由来製剤
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors

Also Published As

Publication number Publication date
EA003182B1 (ru) 2003-02-27
DK0991416T3 (da) 2003-02-10
CN1272061A (zh) 2000-11-01
BG104117A (en) 2000-12-29
NO20000578L (no) 2000-03-27
WO1999007390A1 (en) 1999-02-18
JP2001513507A (ja) 2001-09-04
PL338794A1 (en) 2000-11-20
EA200000196A1 (ru) 2000-10-30
DK0991416T4 (da) 2008-02-25
AU742427B2 (en) 2002-01-03
DE69808620T3 (de) 2008-05-21
EP0991416A1 (en) 2000-04-12
HUP0004795A3 (en) 2003-08-28
DE69808620D1 (de) 2002-11-14
CA2299421C (en) 2009-11-10
RS50016B (sr) 2008-09-29
PT991416E (pt) 2003-02-28
EP0991416B2 (en) 2007-10-31
HUP0004795A2 (hu) 2001-04-28
ID24308A (id) 2000-07-13
NO326216B1 (no) 2008-10-20
CZ293726B6 (cs) 2004-07-14
BG64350B1 (bg) 2004-11-30
ES2185218T5 (es) 2008-04-16
HU226548B1 (en) 2009-03-30
YU5800A (sh) 2003-02-28
CA2299421A1 (en) 1999-02-18
EP0896824A1 (en) 1999-02-17
US20110008459A1 (en) 2011-01-13
ATE225665T1 (de) 2002-10-15
NZ502661A (en) 2001-03-30
IL134308A0 (en) 2001-04-30
AU9256998A (en) 1999-03-01
EP0991416B1 (en) 2002-10-09
CZ2000370A3 (cs) 2000-09-13
ES2185218T3 (es) 2003-04-16
NO20000578D0 (no) 2000-02-04
IL134308A (en) 2004-09-27
DE69808620T2 (de) 2003-06-26
TW555563B (en) 2003-10-01
BR9811839A (pt) 2000-08-15
PL193983B1 (pl) 2007-04-30

Similar Documents

Publication Publication Date Title
HK1026146A1 (en) A universally applicable blood plasma
HK1017883A1 (en) Antiparasitic marcfortines
EP0620240A3 (en) Process for the production of (co) polycarbonates.
EP0636617A3 (de) Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin.
HK1032785A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
ZA943163B (en) Mixing arrangements.
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
AU3689193A (en) Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
GB9425735D0 (en) Pillar bipolar transistors
FR2689518B1 (fr) Microorganismes, procédé de préparation et utilisation.
EP0739896A3 (de) Verfahren zur Herstellung von 6-Oxo-(6H)-dibenz-(c,e)(1,2)-oxaphosphorinen
AU6670690A (en) Benzothiazepines
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
DE69320095T2 (de) 3,9-Bis(Dialkylamino)-2,4,8,10-Tetraoxa-3,9-Diphosphaspiro 5.5-Undecane und stabilisierte Zusammensetzung
AU5545598A (en) Processes for the preparation of alphagal(1$m(7)4)betagal(1$m(7)4)glc-or
ZA966542B (en) Process for the preparation of 3,3,5-trichloroglutarimide.
IL110925A0 (en) Process for the preparation of 1,2-benzisothiazoles
BG102535A (en) Dihydrate of (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate of 4,10 beta-diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa[g]tax-11-ene 13-alpha -yl and method for its preparaton
Reinhart Mandella he ain't
FR2705667B1 (fr) Procédé de préparation d'une cétone cyclique.
ZA983781B (en) Process for the preparation of 1,1,1,3,3-pentachlorobutane.
EP0585682A3 (en) Process for the preparation of 2,6-dimethylmorpholine from n-(2-hydroxypropyl)-2,6-dimethylmorpholine
HU9603541D0 (en) Novel compounds useful again carcinosis and leukemia, process for producing them and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060804